Mangalam Drugs and Organics Ltd

NSE: MANGALAM BSE: 532637

₹31.89

(-3.97%)

Sat, 14 Mar 2026, 02:53 am

MTF 5xInvest in Mangalam Drugs and Organics Ltd with 5x Leverage Buy with MTF

Market Cap525.02M

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Mangalam Drugs and Organics EV/EBITDA Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	10.46	28.02	29.09	7.35	13.13	7.73	20.85	0	0	5.69	25.04	10.25	12.90	0	5.82	5.62	8.28	121.95	0	17.48
Price to book ratio	0.58	0.58	0.43	0.16	0.41	0.37	0.35	0.30	0.27	1.19	5.93	2.66	2.47	0.91	0.46	1.20	1.08	1.02	1.08	0.79
Price to sales ratio	0.21	0.26	0.18	0.06	0.15	0.12	0.09	0.06	0.05	0.16	1.36	0.76	0.92	0.38	0.17	0.41	0.36	0.42	0.40	0.37
Price to cash flow ratio	7.78	0	4.67	2.39	8.62	70.23	0	0	0	9.46	32.02	6.96	19.99	6.88	2.48	9.36	12.31	6.61	0	4.26
Enterprise value	457.3M	496.35M	442.81M	420.5M	565.42M	666.73M	729.67M	805.7M	831.19M	1.12B	4.61B	2.92B	3.25B	1.51B	983.83M	2.26B	2.49B	2.41B	2.52B	2.11B
Enterprise value to EBITDA ratio	7.29	9.43	6.97	4.66	5.30	5.32	5.13	0	8.89	5.52	12.21	6.20	6.87	15.30	4.01	4.23	5.43	9.23	16.07	6.20
Debt to equity ratio	0.69	0.77	0.75	0.93	0.98	1.18	1.60	2.78	3.32	2.65	0.97	0.77	0.66	0.68	0.50	0.53	0.58	0.58	0.79	0.64
Return on equity %	0	2.06	1.50	2.20	3.21	4.93	1.55	-36.69	-12.28	23.36	35.28	30.26	20.99	-8.05	8.27	23.83	13.97	0.84	-6.31	4.72

Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio

The Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Mangalam Drugs and Organics Ltd's valuation, profitability, and overall financial performance. Tracking the Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Mangalam Drugs and Organics Ltd (NSE: MANGALAM, BSE: 532637) is currently trading at ₹31.89, with a market capitalization of ₹525.02M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio Current Value

The current Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio stands at 6.20.

The Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

2024: 6.20
2023: 16.07
2022: 9.23
2021: 5.43
2020: 4.23

The decline in Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Mangalam Drugs and Organics Ltd.

Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Mangalam Drugs and Organics Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800